Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co.
Looking at options history for Eli Lilly and Co LLY we detected 87 trades.
If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish expectations and 52% with bearish.
From the overall spotted trades, 28 are puts, for a total amount of $1,641,414 and 59, calls, for a total amount of $4,535,080.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $1180.0 for Eli Lilly and Co, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale activity within a strike price range from $300.0 to $1180.0 in the last 30 days.
Eli Lilly and Co Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | TRADE | BEARISH | 06/20/25 | $69.95 | $61.05 | $69.9 | $700.00 | $209.7K | 8 | 0 |
| LLY | PUT | TRADE | BULLISH | 06/20/25 | $68.5 | $62.25 | $63.75 | $700.00 | $191.2K | 8 | 30 |
| LLY | PUT | SWEEP | BEARISH | 04/19/24 | $23.25 | $22.65 | $23.25 | $770.00 | $88.3K | 1.0K | 391 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $41.0 | $40.45 | $41.0 | $900.00 | $82.0K | 1.4K | 206 |
| LLY | PUT | TRADE | NEUTRAL | 04/19/24 | $24.15 | $22.55 | $23.35 | $770.00 | $81.7K | 1.0K | 356 |
About Eli Lilly and Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Current Position of Eli Lilly and Co
- With a trading volume of 2,149,032, the price of LLY is up by 0.15%, reaching $747.87.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 13 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly and Co, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
